Sinoway Industrial Co., Ltd.

Apixaban 503612-47-3 Apixaban 503612-47-3

Apixaban 503612-47-3
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic information of Apixaban :

Name

Apixaban

Alias

1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide

CAS NO.

503612-47-3

Molecular Formula

C25H25N5O4

Molecular Weight

459.504

EINECS

1308068-626-2

Brief Introduction

Apixaban is a novel, oral, reversible, highly selective, direct Factor Xa inhibitor developed by Pfizer and Bristol-Myers Squibb.

Storage condition

Room temperature, seal.


Use of Apixaban:

The results of the study show that compared with traditional anticoagulants, Apixaban is more effective and does not increase or decrease the risk of bleeding. Currently, the US FDA and the European EMA have approved Apixaban for prevention of venous thromboembolism (also known as venous thromboembolism or VTE) in adults undergoing total hip or total knee arthroplasty to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation ( Also known as atrial fibrillation stroke), treatment of deep vein thromboembolism (also known as deep vein thrombosis or DVT) and pulmonary embolism (also known as PE), and prevention of recurrence of DVT and PE.

COA of Apixaban :


Apixaban 503612-47-3


  • Iron Sucrose 8047-67-4
    Basic informationOther Names: Iron(III) saccharateCAS No.: 8047-67-4 Appearance:Brown-dark liquid Document: GMP/DMF/Technical support.Appearance:Brown-dark liquid UsageAnti-anemia medicine, which ca... Iron Sucrose 8047-67-4
  • Lacosamide 175481-36-4
    Basic information of Lacosamide :NameLacosamideAlias(2R)-2-acetamido-N-benzyl-3-methoxy-propanamide;(2R)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide;ADD 243037;Erlosamide;Harkoseride;SPM 927... Lacosamide 175481-36-4
  • Mirtazapine 85650-52-8
    Basic information of Mirtazapine:NameMirtazapineAlias(rs)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino-[2,1-a]pyrido[2,3-c][2]benzazepineCAS Number85650-52-8Molecular FormulaC17H19N3Molecular Weight265.3... Mirtazapine 85650-52-8
  • Telmisartan 144701-48-4
    Basic information of Telmisartan:NameTelmisartanMolecular FormulaC33H30N4O2Molecular Weight514.63Quality StandardEP/USPPackage Size25kg/drumBrief IntroductionTelmisartan is an angiotensin II receptor ... Telmisartan 144701-48-4

MORE_DETAIL Apixaban 503612-47-3

Basic information of Apixaban :

Name

Apixaban

Alias

1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide

CAS NO.

503612-47-3

Molecular Formula

C25H25N5O4

Molecular Weight

459.504

EINECS

1308068-626-2

Brief Introduction

Apixaban is a novel, oral, reversible, highly selective, direct Factor Xa inhibitor developed by Pfizer and Bristol-Myers Squibb.

Storage condition

Room temperature, seal.


Use of Apixaban:

The results of the study show that compared with traditional anticoagulants, Apixaban is more effective and does not increase or decrease the risk of bleeding. Currently, the US FDA and the European EMA have approved Apixaban for prevention of venous thromboembolism (also known as venous thromboembolism or VTE) in adults undergoing total hip or total knee arthroplasty to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation ( Also known as atrial fibrillation stroke), treatment of deep vein thromboembolism (also known as deep vein thrombosis or DVT) and pulmonary embolism (also known as PE), and prevention of recurrence of DVT and PE.

COA of Apixaban :


Apixaban 503612-47-3

Leave a Message Email Us

we will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//